enVVeno Medical Corporati... (NVNO)
2.60
-0.15 (-5.45%)
At close: Mar 31, 2025, 12:35 PM
enVVeno Medical Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
| Revenue | n/a | n/a | n/a | n/a | n/a | 31.24K | 186.55K | 422.11K | 785.91K | n/a | 236.5K |
| Cost of Revenue | n/a | 546K | 525K | 452.91K | 383.97K | n/a | n/a | 419.66K | 810.29K | 125.42K | 132.31K |
| Gross Profit | n/a | -546K | -525K | -452.91K | -383.97K | 31.24K | 186.55K | 2.45K | -24.38K | -125.42K | 104.19K |
| Operating Income | -23.83M | -25.24M | -24.93M | -16.89M | -9.14M | -7.68M | -7.85M | -6.1M | -4.66M | -1.29M | -952.66K |
| Interest Income | 389K | 180K | 161K | 19K | 3.74K | 49.91K | n/a | n/a | n/a | n/a | 65.49K |
| Pretax Income | -21.82M | -23.52M | -24.67M | -16.53M | -9.14M | -7.63M | -13.04M | -7.79M | -5.59M | -1.38M | -1.02M |
| Net Income | -21.82M | -23.52M | -24.3M | -16.2M | -8.92M | -7.63M | -13.04M | -7.79M | -3.39M | -1.6M | -1.02M |
| Selling & General & Admin | 11.58M | 11.65M | 15.02M | 11.16M | 4.88M | 4.91M | 6.48M | 5.46M | 4.63M | 1.29M | 1.06M |
| Research & Development | 12.25M | 13.58M | 9.91M | 5.73M | 4.25M | 2.21M | 1.24M | 649.74K | n/a | n/a | n/a |
| Other Expenses | n/a | n/a | n/a | 33.27K | -215.91K | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 23.83M | 25.24M | 24.93M | 16.89M | 9.14M | 7.12M | 7.72M | 6.11M | 4.63M | 1.29M | 1.06M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 6.86M | 209.51K | 57.89K | 88.52K | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | n/a | 25.24M | 24.93M | 16.89M | 9.14M | 7.12M | 7.72M | 6.53M | 5.45M | 1.29M | 1.19M |
| Income Tax | n/a | n/a | -365K | -331.41K | -215.55K | 863.54K | 1.67M | 209.51K | -2.14M | 314.34K | n/a |
| Shares Outstanding (Basic) | 17.14M | 12.3M | 11.23M | 8.68M | 1.29M | 630.42K | 374.5K | 387.69K | 438.72K | 438.72K | 239K |
| Shares Outstanding (Diluted) | 17.14M | 12.3M | 11.23M | 8.68M | 1.29M | 630.42K | 374.5K | 387.69K | 438.72K | 438.72K | 240K |
| EPS (Basic) | -1.27 | -1.91 | -2.16 | -1.87 | -6.91 | -12.1 | -34.83 | -20.1 | -7.72 | -3.66 | -4.26 |
| EPS (Diluted) | -1.27 | -1.91 | -2.16 | -1.87 | -6.91 | -12.1 | -34.83 | -20.1 | -7.72 | -3.66 | -4.24 |
| EBITDA | -23.83M | -25.02M | -24.51M | -16.75M | -8.75M | -6.96M | -6.05M | -5.73M | -5.38M | -1.16M | -818.53K |
| Depreciation & Amortization | n/a | 220K | 525K | 452.91K | 383.97K | 396.67K | 133.42K | 139.21K | 151.17K | 125.42K | 134.13K |